Gau-Algesheim, Germany

Daniela Eberts


 


Average Co-Inventor Count = 9.0

ph-index = 1


Location History:

  • Finthen, DE (2018)
  • Gau-Algesheim, DE (2021)

Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniela Eberts

Introduction

Daniela Eberts is a distinguished inventor based in Gau-Algesheim, Germany. She has made significant strides in the field of immunology, particularly in the development of novel tumor-associated antigens. With a total of two patents to her name, Eberts is at the forefront of innovations aiming to enhance cancer treatments and diagnostics.

Latest Patents

Eberts' most recent patents focus on MHC-independent tumor-associated antigens. These inventions aim to elicit a CD8-positive T-cell response without relying on traditional MHC presentation. The patents highlight her discoveries involving GM-CSF-Receptor alpha chain (CSF2RA) and Tyrosinase-related protein 2 (TRP-2), which are critical targets of CD8-positive T-cell clones that can identify proteins on HLA I negative melanoma cells. Her work offers promising applications in medicine, including the treatment, diagnosis, and prevention of tumor diseases. Additionally, her inventions encompass proteins, protein fragments, polypeptides, and even pharmaceutical compositions, such as vaccine formulations designed to stimulate T-cell responses in an MHC-independent manner.

Career Highlights

Throughout her career, Eberts has garnered valuable experience at notable institutions. She worked with BioNTech RNA Pharmaceuticals GmbH, a company recognized for its groundbreaking work in mRNA technology, particularly in the realm of cancer immunotherapy. Furthermore, she has contributed to research at Universitätsmedizin der Johannes Gutenberg-Universität Mainz, enhancing her expertise in medical science and innovation.

Collaborations

Eberts has collaborated with eminent colleagues in her field, such as Dirk Schadendorf and Annette Paschen. Their joint efforts have undoubtedly fostered research advancements and the successful development of innovative therapeutic strategies.

Conclusion

Daniela Eberts exemplifies the spirit of innovation within the scientific community. Her contributions to the field of immunology through her patented inventions highlight her commitment to improving cancer treatment options. As she continues to explore the potentials of tumor-associated antigens, her work holds promise for the future of medical science and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…